Competitors Within
Home-grown smaller players are giving biggies a run for their money in the US generics market.
indian pharma
November 2021
October 2021
Quality issues remain for Indian pharma companies: USFDA
The problems faced by FDA’s investigators in India are similar to those around the world, US Food and Drug Administration spokesperson Jeremy Kahn tells Fortune India.
